Inhibiting Gβγ to produce these shifts in cytokine mRNA production might be beneficial for patients with autoimmune diseases such as rheumatoid arthritis (RA), Crohn's disease (CD), psoriasis, multiple sclerosis (MS), and Hashimoto's thyroiditis (HT), in which both IFN-γ and IL-17A are elevated.
Keyphrases
- multiple sclerosis
- rheumatoid arthritis
- induced apoptosis
- disease activity
- dendritic cells
- mass spectrometry
- cell cycle arrest
- signaling pathway
- nk cells
- immune response
- ankylosing spondylitis
- regulatory t cells
- binding protein
- interstitial lung disease
- white matter
- cell death
- systemic lupus erythematosus
- systemic sclerosis
- idiopathic pulmonary fibrosis
- oxidative stress